Dashboard
Manage Tickers

ABBVAbbVie Inc.


$ 193.49 $ -2.28 (-1.16 %)    

Tuesday, 17-Sep-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 193.45
$ 194.59
$ 193.46 x 100
$ 200.00 x 245
$ 191.83 - $ 195.89
$ 132.11 - $ 199.95
3,534,110
na
341.7B
$ 0.63
$ 64.00
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ripple-therapeutics-announces-collaboration-and-option-to-license-agreement-with-abbvie-to-develop-biodegradable-sustained-release-drug-delivery-implants-for-glaucoma-management
Ripple Therapeutics Announces Collaboratio...
09/17/2024 12:52:56

transdigm-bjs-wholesale-abbvie-and-more-on-cnbcs-final-trades
TransDigm, BJ's Wholesale, AbbVie And More...
09/17/2024 11:55:33

TransDigm Group (TDG), BJ's Wholesale (BJ), VanEck Semiconductor ETF (SMH), and AbbVie (ABBV) were recommended as top trade...

Core News & Articles
CNBC Halftime Report Final Trades: Taiwan ...
09/16/2024 17:01:43

unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars
UnitedHealth Follows Competitors, Replaces...
09/11/2024 18:59:13

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

what-the-options-market-tells-us-about-abbvie
What the Options Market Tells Us About AbbVie
09/11/2024 17:31:35

abbvies-allergan-aesthetics-launches-botox-cosmetic-for-masseter-muscle-prominence-in-adults-in-china
AbbVie's Allergan Aesthetics Launches BOTO...
09/11/2024 12:33:04

teva-announces-80m-settlement-to-baltimore-city-continues-opioid-litigation-against-other-companies
Teva Announces $80M Settlement To Baltimor...
09/10/2024 18:09:13

Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated ...

Core News & Articles
UnitedHealth Group Says It Will Remove Abb...
09/10/2024 16:26:00

- Reuters 

Core News & Articles
Unitedhealth Says It Will Remove Abbvie's ...
09/10/2024 16:22:36

- Reuters 

abbvies-constella-receives-health-canada-approval-for-treating-childhood-constipation
AbbVie's CONSTELLA Receives Health Canada ...
09/10/2024 11:09:02

AbbVie (NYSE:ABBV), today announced that Health Canada has approved CONSTELLA® (linaclotide) as a once-daily oral treatment for...

spotlight-on-abbvie-analyzing-the-surge-in-options-activity
Spotlight on AbbVie: Analyzing the Surge i...
09/09/2024 20:15:52

abbvie-to-present-new-data-from-antibody-drug-conjugate-adc-platform-at-esmo-congress-2024-highlighting-mirvetuximab-soravtansine-for-ovarian-cancer-telisotuzumab-vedotin-and-adizutecan-for-non-small-cell-lung-and-gastroesophageal-cancers
AbbVie To Present New Data From Antibody-D...
09/09/2024 13:08:25

Full data from the primary analysis of the positive, single-arm Phase 2 PICCOLO trial, evaluating mirvetuximab soravtansine (EL...

peering-into-abbvies-recent-short-interest
Peering Into AbbVie's Recent Short Interest
09/06/2024 19:30:22

psychedelic-drugs-market-set-to-grow-by-137b-by-2028-driven-by-mental-health-disorders-and-ai-integration
Psychedelic Drugs Market Set To Grow By $1...
09/05/2024 16:53:46

The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI adva...

heres-how-much-100-invested-in-abbvie-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In AbbVie 10...
09/05/2024 15:00:22

abbvie-announces-vraylar-receives-reimbursement-recommendation-from-canadas-drug-agency-for-treatment-of-schizophrenia-in-adults-following-successful-negotiations-and-loi
AbbVie Announces VRAYLAR Receives Reimburs...
09/04/2024 12:02:08

VRAYLAR, an atypical antipsychotic medication, received its Notice of Compliance from Health Canada on April 22, 2022.Following...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/03/2024 17:35:17

abbvie-options-trading-a-deep-dive-into-market-sentiment
AbbVie Options Trading: A Deep Dive into M...
08/29/2024 19:31:56

as-regulators-gear-up-to-decide-on-bristol-myers-schizophrenia-treatment-neurocrine-biosciences-data-disappoints-investors
As Regulators Gear Up To Decide On Bristol...
08/28/2024 15:16:26

Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms,...

regulators-expected-to-approve-innovative-schizophrenia-treatment-from-bristol-myers-karuna
Regulators Expected To Approve Innovative ...
08/27/2024 19:22:11

Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomb...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION